Showing results (71-80 of 183) with videos related to
Sort By:
Pageof 19
Haematologica|December 23, 2021
Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemiaKaren L Bride, Hai Hu, Anastasia Tikhonova, et al.Nutrients|March 9, 2013
Selenium for the prevention of cutaneous melanomaPamela B Cassidy, Heidi D Fain, James P Cassidy, et al.Journal of Pediatric Hematology/Oncology|November 27, 2013
A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortiumElizabeth A Raetz, Debra Morrison, Eleny Romanos-Sirakis, et al.Blood|September 15, 2022
Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 studyLuke Maese, Mignon L Loh, Mi Rim Choi, et al.Biorxiv : the Preprint Server for Biology|July 9, 2025
Single-cell RNA sequencing in Hirschsprung's disease tissues reveals lack of neuronal differentiation in the aganglionic colon segmentSzabolcs Tarapcsak, Xiaomeng Huang, Yi Qiao, et al.British Journal of Haematology|July 5, 2014
Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemiaSmita Dandekar, Eleny Romanos-Sirakis, Faye Pais, et al.Translational Oncology|November 22, 2020
A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancerFeng Chi, Jiayi Liu, Samuel W Brady, et al.Genome Research|January 9, 2024
A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing dataYi Qiao, Xiaomeng Huang, Philip J Moos, et al.Nature Communications|August 28, 2024
Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemiaSonali Narang, Yohana Ghebrechristos, Nikki A Evensen, et al.Pediatric Blood & Cancer|November 2, 2017
Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology GroupRachel E Rau, ZoAnn Dreyer, Mi Rim Choi, et al.Pageof 19